The Daily Folgen

The opioid epidemic has been one of the biggest public health disasters in generations. The drug company at the heart of the crisis, Purdue Pharma, maker of the prescription painkiller OxyContin, agreed to a multibillion-dollar deal to settle thousands of claims against it — but that agreement would also grant the family behind the company, the Sacklers, immunity from additional civil lawsuits.Justices are now set to rule whether that settlement was legal. Abbie VanSickle, who covers the Supreme Court for The Times, explains what a decision either way could mean for the victims and for the people responsible.Guest: Abbie VanSickle, a Supreme Court correspondent for The New York Times.Background reading:What to know about the Purdue Pharma case before the Supreme Court.At the core of the matter: Who can get immunity in settlements?For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

As a racketeering trial begins in Atlanta, much of the focus is on the high-profile defendant, the best-selling rapper Young Thug.Joe Coscarelli, a culture reporter for The New York Times, explains why, in a sense, hip-hop itself is on trial.Guest: Joe Coscarelli, a culture reporter for The New York Times.Background reading: A judge ruled in November that at least 17 specific sets of lines from the Atlanta artist and his collaborators could be used by prosecutors in the racketeering trial of YSL, a chart-topping hip-hop label and collective.Here’s what to know about the trial.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

 In the weeks since Hamas carried out its devastating terrorist attack in southern Israel, Times journalists have been trying to work out why the Israeli security services failed to prevent such a huge and deadly assault.Ronen Bergman, a correspondent for The New York Times, tells the story of one of the warnings that Israel ignored.Guest: Ronen Bergman, a staff writer for The New York Times Magazine.Background reading: A blueprint reviewed by The Times laid out the Oct. 7 attack in detail. Israeli officials dismissed it as aspirational.Here’s the latest on the war.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.